36. Epidermolysis bullosa Clinical trials / Disease details


Clinical trials : 160 Drugs : 195 - (DrugBank : 47) / Drug target genes : 50 - Drug target pathways : 124

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01340235
(ClinicalTrials.gov)
June 201111/4/2011Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinTreatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinEpidermolysis BullosaDrug: Oral erythromycinCentre Hospitalier Universitaire de NiceNULLRecruiting6 Months8 YearsBoth8Phase 3France